Assessment of the benefits and risks of cancer treatments

Alham Delroba

The role of the partitioning defective protein 6 (Par6) and phosphatidylinositide 3-kinases (PI3K) signaling axis in transforming growth factor beta tumour suppressor in breast cancer metastasis

Breast

Norman Wolmark

NRG Oncology Network Group Operations Center

Trachea, bronchus and lung Stomach Prostate Pancreas Ovary Oesophagus Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system Bladder

Radiation Oncology Surgery / Surgical oncology

Lindsay Morton

Childhood cancer survivor study (CCSS)

Sarcoma Thyroid Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Melanoma of skin Lip, oral cavity Leukaemia Larynx Kidney, renal pelvis and ureter Hodgkin lymphoma Breast Brain, nervous system

Radiation Oncology Pediatric oncology or childhood cancer

Karin B Michels

Environmental chemicals and postpubertal breast composition in a Latino cohort

Breast

Chandra Bartholomeusz

Development of Targeted Therapy for ERK Pathway in Breast Cancer

Breast

Lisa M Coussens

Regulating the Immune Microenvironment in Breast Cancer

Breast

Meir Stampfer

Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study

Colorectum Breast

Judith A Varner

Role of PI3Kinase Gamma in Tumor Progression and Metastasis

Breast

Investigator from University Of Amsterdam

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome

Breast